Jim Simons Cabaletta Bio, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 126,100 shares of CABA stock, worth $297,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,100

Previous 10,900 1056.88%

Holding current value

$297,596

Previous $15,000 1173.33%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.04 - $2.48 $119,808 - $285,696	115,200 Added 1056.88%	126,100 $191,000
Q1 2025 May 14, 2025	SELL	$1.39 - $2.74 $304,772 - $600,775	-219,261 Reduced 95.26%	10,900 $15,000
Q4 2024 Feb 13, 2025	BUY	$1.87 - $4.91 $430,401 - $1.13 Million	230,161 New	230,161 $506,000
Q1 2024 May 13, 2024	BUY	$16.79 - $25.38 $990,610 - $1.5 Million	59,000 New	59,000 $1.01 Million
Q2 2023 Aug 11, 2023	SELL	$7.65 - $13.95 $268,515 - $489,645	-35,100 Reduced 31.12%	77,700 $1 Million
Q1 2023 May 12, 2023	SELL	$7.08 - $12.62 $358,248 - $638,572	-50,600 Reduced 30.97%	112,800 $933,000
Q4 2022 Feb 13, 2023	SELL	$0.64 - $9.3 $335,399 - $4.87 Million	-524,061 Reduced 76.23%	163,400 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $2.05 $222,050 - $722,545	352,461 Added 105.21%	687,461 $447,000
Q2 2022 Aug 12, 2022	BUY	$0.99 - $2.11 $134,244 - $286,116	135,600 Added 68.0%	335,000 $355,000
Q1 2022 May 13, 2022	BUY	$1.68 - $3.92 $334,992 - $781,648	199,400 New	199,400 $405,000
Q3 2021 Nov 12, 2021	SELL	$7.0 - $12.5 $104,300 - $186,250	-14,900 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.2 - $11.73 $107,280 - $174,777	14,900 New	14,900 $128,000
Q3 2020 Nov 13, 2020	SELL	$9.71 - $14.41 $596,650 - $885,451	-61,447 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.39 - $11.28 $309,576 - $546,482	48,447 Added 372.67%	61,447 $685,000
Q1 2020 May 14, 2020	BUY	$6.0 - $18.67 $78,000 - $242,710	13,000 New	13,000 $95,000

Others Institutions Holding CABA

# of Institutions

Shares Held

77.1M

Call Options Held

406K

Put Options Held

90.9K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $68.5M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account